2025年港股市场上,百奥赛图(02315.HK)的股价从年初8.50港元/股飙涨到27.50港元/股(9月19日收盘),涨幅达223.53%,头顶“基因编辑第一股”光环的它,将于9月24日上会审议,为冲击科创板实现A+H两地上市做关键一搏。但光鲜股价背后,其五年亏掉近19亿、专职研发人员仅剩5人的窘境,都让这场资本闯关充满疑云。01资本局募资缩水7亿,实控人举债救场百奥赛图是一家临床前CRO以及...
Source Link2025年港股市场上,百奥赛图(02315.HK)的股价从年初8.50港元/股飙涨到27.50港元/股(9月19日收盘),涨幅达223.53%,头顶“基因编辑第一股”光环的它,将于9月24日上会审议,为冲击科创板实现A+H两地上市做关键一搏。但光鲜股价背后,其五年亏掉近19亿、专职研发人员仅剩5人的窘境,都让这场资本闯关充满疑云。01资本局募资缩水7亿,实控人举债救场百奥赛图是一家临床前CRO以及...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.